跳至主要内容
临床试验/NCT07538622
NCT07538622招募中不适用

Prospective Post Market Clinical Registry for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH Spring System Registry

Zenflow, Inc.13 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2026年7月29日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Zenflow, Inc.
入组人数
300
试验地点
13
主要终点
Effectiveness - IPSS

研究概览

简要总结

The purpose of this registry is to collect information on how the Zenflow Spring System works in everyday medical practice. The registry will track how the Spring System performs during the implant procedure, and at follow-up visits at 1, 3, 6, and 12 months. We will look at how symptoms improve, how quickly patients return to normal activities, how satisfied they are with treatment, and whether there are any problems or side effects related to the device.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Treatment with Zenflow Spring System will be conducted in accordance with the approved Instructions for Use

排除标准

  • Treatment with Zenflow Spring System will be conducted in accordance with the approved Instructions for Use

结局指标

主要结局

Effectiveness - IPSS

时间窗: Baseline to 12 Months

The primary effectiveness endpoint is the change in IPSS from baseline over time

Safety - adverse events

时间窗: Baseline to 12 Months

The primary safety endpoint is the observed rate of device-related serious adverse events (SAEs)

次要结局

未报告次要终点

研究者

发起方
Zenflow, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验